List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 132 studies with search of:   "Taxane"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Terminated Adjuvant Epirubicin/Cytoxan Followed By A Taxane VS. Epirubicin/Taxane As Treatment For Node-Positive Breast Cancer
Condition: Adenocarcinoma
Interventions: Drug: Epirubicin with Cyclophosphamide, followed by a Taxane;   Drug: Epirubicin with a Taxane
2 Completed A Phase III Randomized Trial Assessing the Utility of a Test Dose Program With Taxanes
Conditions: Supportive;   Ill-Defined Sites
Interventions: Drug: paclitaxel, docetaxel, taxane;   Drug: taxane
3 Completed Oral Taxane in Combination With Pemetrexed (Alimta) in Patients With Recurrent Non-Small Cell Lung Cancer
Condition: Non-Small Cell Lung Cancer
Intervention: Drug: Oral Taxane
4 Recruiting A Study of Avastin (Bevacizumab) Plus Taxane-Based Therapy in Patients With Locally Recurrent or Metastatic Breast Cancer.
Condition: Breast Cancer
Interventions: Drug: bevacizumab [Avastin];   Drug: Taxane-based chemotherapy
5 Terminated A Phase I Study of BMS-275183 (Oral Taxane) Given on a Daily Schedule in Combination With Esomeprazole (Nexium) in Patients With Advanced Cancer
Condition: Cancer
Intervention: Drug: Oral Taxane
6 Active, not recruiting Evaluation of Differing Taxanes/Taxane Combinations on the Outcome of Patients With Operable Breast Cancer
Condition: Breast Cancer
Interventions: Drug: Paclitaxel;   Drug: Docetaxel;   Drug: Capecitabine
7 Recruiting A Study of Herceptin (Trastuzumab) in Women With Metastatic Breast Cancer
Condition: Breast Cancer
Interventions: Drug: trastuzumab [Herceptin];   Drug: Taxane (docetaxel or paclitaxel)
8 Completed Evaluation of Bay 59-8862 in Taxane-Resistant Metastatic Breast Cancer Patients
Conditions: Breast Neoplasms;   Metastases, Neoplasm
Intervention: Drug: Bay 59-8862
9 Completed Evaluation of Bay 59-8862 in Taxane Resistant Non-Small Cell Lung Cancer Patients
Condition: Carcinoma, Non-Small-Cell Lung
Intervention: Drug: Bay 59-8862
10 Terminated Liposomal Doxorubicin and Estramustine Phosphate: Study in Taxane Resistant, Hormone Refractory Advanced Prostate Cancer
Condition: Prostate Cancer
Intervention: Drug: Doxil and Estramustine
11 Completed Ispinesib In Subjects With Platinum-Taxane-Refractory Or Resistant Relapsed Ovarian Cancer
Condition: Ovarian Cancer
Intervention: Drug: Ispinesib
12 Completed PS-341 Plus Carboplatin in Platinum and Taxane Resistant Recurrent Ovarian Cancer, Primary Peritoneal Cancer, and Fallopian Tube Cancer
Conditions: Ovarian Cancer;   Primary Peritoneal Cancer;   Fallopian Tube Cancer
Interventions: Drug: PS-341 (Bortezomib);   Drug: Carboplatin
13 Active, not recruiting Gemcitabine Monotherapy for Metastatic Breast Cancer After Anthracycline and Taxane Regimen
Condition: Metastatic Breast Cancer
Intervention: Drug: gemcitabine
14 Recruiting SU11248 as Consolidation After Response to Taxanes in Metastatic Breast Cancer
Condition: Metastatic Breast Cancer
Intervention: Drug: SU11248
15 Completed Study of Taxane/Carboplatin +/- Cetuximab as First-Line Treatment for Patients With Advanced/Metastatic Non-Small Cell Lung Cancer
Condition: Non-Small-Cell Lung Carcinoma
Interventions: Drug: Paclitaxel (or Docetaxel) + carboplatin w/ cetuximab;   Drug: Paclitaxel (or Docetaxel) + carboplatin
16 Terminated A Phase I Study of a Single Dose of Radio-Labeled BMS-275183 in Patients With Advanced Cancer
Condition: Cancer
Intervention: Drug: Oral Taxane
17 Recruiting Patupilone Versus Doxorubicin in Patients With Ovarian, Primary Fallopian, or Peritoneal Cancer
Conditions: Ovarian Cancer;   Fallopian Tube Cancer;   Peritoneal Neoplasms
Interventions: Drug: EPO906 (Patupilone);   Drug: Doxil
18 Active, not recruiting A Study of Patients With HER2 Gene Amplified Metastatic Breast Cancer Treated With First Line Herceptin and a Taxane
Conditions: Breast Cancer;   Metastases
Intervention:
19 Completed Pemetrexed Plus Gemcitabine in Metastatic Breast Cancer Patients After Receiving Taxane Therapy
Conditions: Breast Cancer;   Cancer of Breast;   Cancer of the Breast;   Breast Neoplasms
Interventions: Drug: Pemetrexed;   Drug: Gemcitabine
20 Recruiting Phase II Study of Ironotecan Plus Capecitabine in Patients With Antracycline and Taxane Pretreated Metastatic Breast Cancer
Condition: Breast Cancer Metastatic
Intervention: Drug: Irinotecan plus capecitabine

Previous Page Studies Shown (1-20) Next (21-40)
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services